Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Welch David F	2. Issuer Name and Ticker or Trading Symbol INFINERA CORP [ INFN ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ X __ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) President
(Last) (First) (Middle) C/O INFINERA CORPORATION, 140 CASPIAN COURT	3. Date of Earliest Transaction (MM/DD/YYYY) 2/5/2016
(Street) SUNNYVALE, CA 94089 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	2/5/2016		M		20000	A	$0.00	293709	I	See Footnote ⁽¹⁾
Common Stock	2/5/2016		F		7747	D	$14.40	285962	I	See Footnote ⁽¹⁾
Common Stock	2/5/2016		M		37500	A	$0.00	323462	I	See Footnote ⁽¹⁾
Common Stock	2/5/2016		F		14093	D	$14.40	309369	I	See Footnote ⁽¹⁾
Common Stock	2/5/2016		M		20923	A	$0.00	330292	I	See Footnote ⁽¹⁾
Common Stock	2/5/2016		F		9174	D	$14.40	321118	I	See Footnote ⁽¹⁾
Common Stock	2/5/2016		M		9015	A	$0.00	330133	I	See Footnote ⁽¹⁾
Common Stock	2/5/2016		F		4705	D	$14.40	325428	I	See Footnote ⁽¹⁾
Common Stock								140000	I	See Footnote ⁽²⁾
Common Stock								319493	I	See Footnote ⁽³⁾
Common Stock								553750	I	See Footnote ⁽⁴⁾
Common Stock								2500	I	See Footnote ⁽⁵⁾
Common Stock								14132	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$2.00							⁽⁶⁾	8/8/2016	Common Stock	50000		50000	D
Employee Stock Option (Right to Buy)	$2.00							⁽⁶⁾	8/8/2016	Common Stock	137500		137500	D
Employee Stock Option (Right to Buy)	$8.19							⁽⁶⁾	11/23/2016	Common Stock	75000		75000	D
Employee Stock Option (Right to Buy)	$7.61							⁽⁶⁾	6/6/2017	Common Stock	29214		29214	D
Employee Stock Option (Right to Buy)	$7.61							⁽⁶⁾	6/6/2017	Common Stock	101342		101342	D
Employee Stock Option (Right to Buy)	$7.61							⁽⁶⁾	2/28/2018	Common Stock	2817		2817	D
Employee Stock Option (Right to Buy)	$7.61							⁽⁶⁾	2/28/2018	Common Stock	81683		81683	D
Employee Stock Option (Right to Buy)	$7.11							⁽⁶⁾	2/10/2019	Common Stock	100000		100000	D
Employee Stock Option (Right to Buy)	$7.45							⁽⁶⁾	8/10/2019	Common Stock	150000		150000	D
Employee Stock Option (Right to Buy)	$8.58							⁽⁶⁾	2/10/2021	Common Stock	20250		20250	D
Employee Stock Option (Right to Buy)	$8.58							⁽⁶⁾	2/10/2021	Common Stock	60750		60750	D
Employee Stock Option (Right to Buy)	$8.58							⁽⁶⁾	2/10/2021	Common Stock	39465		39465	D
Employee Stock Option (Right to Buy)	$8.58							⁽⁶⁾	2/10/2021	Common Stock	41535		41535	D
Restricted Stock Units	⁽⁷⁾	2/5/2016		M			20000	⁽⁸⁾	⁽⁸⁾	Common Stock	20000	$0.00	0	D
Restricted Stock Units	⁽⁷⁾							⁽⁹⁾	⁽⁹⁾	Common Stock	24000		24000	D
Restricted Stock Units	⁽⁷⁾							⁽¹⁰⁾	⁽¹⁰⁾	Common Stock	41846		41846	D
Restricted Stock Units	⁽⁷⁾							⁽¹¹⁾	⁽¹¹⁾	Common Stock	28770		28770	D
Restricted Stock Units	⁽⁷⁾							⁽¹²⁾	⁽¹²⁾	Common Stock	28770		28770	D
Restricted Stock Units	⁽⁷⁾	2/5/2016		M			37500	⁽¹³⁾	⁽¹³⁾	Common Stock	37500	$0.00	0	D
Restricted Stock Units	⁽⁷⁾	2/5/2016		M			20923	⁽¹⁴⁾	⁽¹⁴⁾	Common Stock	20923	$0.00	0	D
Restricted Stock Units	⁽⁷⁾	2/5/2016		M			9015	⁽¹⁵⁾	⁽¹⁵⁾	Common Stock	9015	$0.00	0	D

Explanation of Responses:
( 1)	These shares are held directly by The Welch Family Trust, for which Dr. Welch is a trustee.
( 2)	These shares are held directly by The Welch Group, for which Dr. Welch is the general partner.
( 3)	These shares are held directly by LRFA, LLC, for which Dr. Welch is the sole managing member.
( 4)	These shares are held directly by SEI Private Trust Company, Trustee of The Welch Family Heritage Trust I u/I dated 9/24/01.
( 5)	These shares are held directly by Dr. Welch as a trustee for his children. Dr. Welch disclaims beneficial ownership of the shares held in trust for his children, and this report shall not be deemed an admission that Dr. Welch is the beneficial owner of the shares held in trust for his children for purposes of Section 16 or for any other purpose.
( 6)	This option is fully-vested.
( 7)	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Infinera Corporation common stock.
( 8)	These RSUs vest in three annual installments beginning on February 5, 2014.
( 9)	These RSUs vest in four annual installments beginning on August 5, 2014.
( 10)	These RSUs vest in three annual installments beginning on May 5, 2015.
( 11)	These RSUs vest in three annual installments beginning on May 5, 2016.
( 12)	These RSUs vest as to 50% of the shares on May 5, 2017 and 50% of the shares on May 5, 2018.
( 13)	This includes 37,500 shares granted pursuant to a performance-based RSU award, which vested and released to Dr. Welch effective February 5, 2016.
( 14)	This includes 20,923 shares granted pursuant to a performance-based RSU award, which vested and released to Dr. Welch effective February 5, 2016.
( 15)	This includes 9,015 shares granted pursuant to a performance-based RSU award, which vested and released to Dr. Welch effective February 5, 2016.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Welch David F C/O INFINERA CORPORATION 140 CASPIAN COURT SUNNYVALE, CA 94089	X		President

Signatures
/s/ Michael Post, by Power of Attorney		2/9/2016
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.